Delivery Order SPE2DB22D3004-SPE2DB25FQE64
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.96 firm fixed-price delivery order is for the supply of Ketorolac 15 mg/ml vials, a pain management medication. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,351.13 firm fixed-price delivery order is for the supply of ketorolac 30 mg/ml vial, a pain management medication. The contract, which does not have a set-aside designation, has an ultimate completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.72 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a medication used for pain management. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.07 firm fixed-price delivery order is for KETOROLAC 30 MG/ML VIALML, a generic pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vial, a pharmaceutical product. The contract has a ceiling value of $1,588.62 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,375.34 firm fixed-price delivery order is for the supply of 4,566,777,822 units of 30 mg/mL ketorolac vials. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award for $1,619.20 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,619.20, is a delivery order to supply the DLA with 4,566,678,521 units of the medication Ketorolac 60 mg/2 ml vial. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,874.80, is a Firm Fixed Price Delivery Order for the supply of Ketorolac 30 mg/mL vials. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for delivering a range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,215.17, is a Firm Fixed Price Delivery Order for the supply of 4567721120 KETOROLAC 30 MG/ML VIALML. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies,...